Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1

To improve the efficacy of immunotherapy for cancer and autoimmune diseases, recent ongoing and completed clinical trials have focused on specific targets to redirect the immune network toward eradicating a variety of tumors and ameliorating the self-destructive process. In a previous review, both s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Yi-chi M., Flynn, Jeffrey C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032988/
https://www.ncbi.nlm.nih.gov/pubmed/24904570
http://dx.doi.org/10.3389/fimmu.2014.00206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032988/
https://www.ncbi.nlm.nih.gov/pubmed/24904570
http://dx.doi.org/10.3389/fimmu.2014.00206

Ejemplares similares